Insulin-like growth factor-I concentration and risk of prostate cancer: results from the European Prospective Investigation into Cancer and Nutrition.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Cancer Epidemiology, Biomarkers and Prevention

• Publication date

  2012-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/1055-9965.EPI-12-0481-TPMID 22761305PMCID PMC5749609
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Disclosure of Potential Conflicts of Interest

  2014cited by this paper
• Circulating insulin-like growth factors and IGF-binding proteins in PSA-detected prostate cancer: the large case-control study ProtecT.

  2012cited by this paper
• Plasma insulin‐like growth factor 1 is positively associated with low‐grade prostate cancer in the Health Professionals Follow‐up Study 1993–2004

  2011cited by this paper
• Androgens, growth factors, and risk of prostate cancer: The Multiethnic Cohort

  2010cited by this paper
• The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition.

  2009cited by this paper
• Gleason scoring system faces change and debate.

  2009cited by this paper
• Prostate Cancer Risk in Relation to Insulin-like Growth Factor (IGF)-I and IGF-Binding Protein-3: A Prospective Multiethnic Study

  2008cited by this paper
• Insulin-like Growth Factors, Their Binding Proteins, and Prostate Cancer Risk: Analysis of Individual Patient Data from 12 Prospective Studies

  2008influential reference
• Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition.

  2007cited by this paper
• Prostate cancer and the Will Rogers phenomenon.

  2005influential reference
• The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

  2005cited by this paper
• Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA era

  2005cited by this paper
• Mechanisms by which IGF-I May Promote Cancer

  2003cited by this paper
• Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations.

  2002cited by this paper
• The associations of diet with serum insulin-like growth factor I and its main binding proteins in 292 women meat-eaters, vegetarians, and vegans.

  2002cited by this paper
• Re: Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.

  2002cited by this paper
• European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection

  2002cited by this paper
• Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations.

  2002cited by this paper
• Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer.

  2002cited by this paper
• Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.

  2000cited by this paper
• Role of the insulin-like growth factor family in cancer development and progression.

  2000cited by this paper
• Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men.

  1999cited by this paper
• Asymptomatic incidence and duration of prostate cancer.

  1998cited by this paper
• Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics.

  1996cited by this paper
• Insulin-like growth factors and their binding proteins: biological actions.

  1995cited by this paper
• What does the odds ratio estimate in a case-control study?

  1993cited by this paper

• Obesity, metformin prescription and risk of advanced prostate cancer in non-diabetic men

  2026cites this paper
• Curcumin inhibits growth and triggers apoptosis in human castration-resistant prostate cancer cells via IGF-1/PI3K/Akt pathway

  2025cites this paper
• Integrated miRNA-mRNA Analyses of Triple-Negative Breast Cancer in Black and White Patients with or Without Obesity

  2025cites this paper
• Interactions between androgen and IGF1 axes in prostate tumorigenesis

  2024cites this paper
• EVOLUTION OF METFORMIN IN BREAST CANCER THERAPY IN LAST TWO DECADES: A REVIEW.

  2024cites this paper
• Dietary Pattern and Cancer.

  2024cites this paper
• Metformin and HER2-positive breast cancer: Mechanisms and therapeutic implications.

  2023cites this paper
• Safety of long-term use of daily and long-acting growth hormone in growth hormone-deficient adults on cancer risk.

  2023cites this paper
• Leptin: A Heavyweight Player in Obesity-Related Cancers

  2023cites this paper
• Effect of iron and calcium on radiation sensitivity in prostate cancer patients relative to controls

  2023cites this paper
• Cognitive fusion-targeted biopsy versus transrectal ultrasonography-guided systematic biopsy: comparison and analysis of the risk of Gleason score upgrading

  2023cites this paper
• A peptide-centric approach to analyse quantitative proteomics data- an application to prostate cancer biomarker discovery.

  2022cites this paper
• Aberrant androgen action in prostatic progenitor cells induces oncogenesis and tumor development through IGF1 and Wnt axes

  2022cites this paper
• Dairy foods, calcium intakes, and risk of incident prostate cancer in Adventist Health Study-2.

  2022cites this paper
• Periprostatic adipose tissue promotes prostate cancer resistance to docetaxel by paracrine IGF‐1 upregulation of TUBB2B beta‐tubulin isoform

  2021cites this paper
• Endocrinology of the Aging Prostate: Current Concepts

  2021cites this paper
• Height in Adolescence as a Risk Factor for Glioma Subtypes: a Nationwide Retrospective Cohort Study of 2.2 Million Subjects.

  2021cites this paper
• Risk Factors Associated with Prostate Cancer

  2021cites this paper
• Mechanistic Insights into the Link between Obesity and Prostate Cancer

  2021cites this paper
• Prostate cancer: Therapeutic prospect with herbal medicine

  2021cites this paper
• Role of Gene Polymorphism in Obesity and Cancer

  2021cites this paper
• The biological and pharmacological connections between diabetes and various types of cancer.

  2021cites this paper
• The Role of Kinase Inhibitors in Cancer Therapies

  2021cites this paper
• Análisis molecular de la multifocalidad en cáncer de próstata como proceso de entendimiento del modelo de carcinogénesis de la enfermedad

  2020cites this paper
• Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy

  2020cites this paper
• Diabetes and cancer: Epidemiological and biological links

  2020cites this paper
• The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF‐I, IGF‐II, IGFBP‐1, IGFBP‐2 and IGFBP‐3 in a pooled analysis of 16,024 men from 22 studies

  2019cites this paper
• Absence of excess body fatness

  2019cites this paper
• Epidemiology of Prostate Cancer

  2019cites this paper
• Nutrient Sensing, Signaling and Ageing: The Role of IGF-1 and mTOR in Ageing and Age-Related Disease.

  2018cites this paper
• Association between serum levels of insulin‐like growth factor‐1, bioavailable testosterone, and pathologic Gleason score

  2018cites this paper
• Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease

  2018cites this paper
• Does soy protein affect circulating levels of unbound IGF-1?

  2018cites this paper
• Obesity and Cancer: Existing and New Hypotheses for a Causal Connection

  2018cites this paper
• Does milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysis

  2017cites this paper
• Tall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort study

  2017cites this paper
• Associations of Calcium and Milk Product Intakes with Incident, Sporadic Colorectal Adenomas

  2017cites this paper
• Pre-diagnostic metabolite concentrations and prostate cancer risk in 1077 cases and 1077 matched controls in the European Prospective Investigation into Cancer and Nutrition

  2017cites this paper
• Insulin‐like growth factor I and risk of incident cancer in elderly men – results from MrOS (Osteoporotic Fractures in Men) in Sweden

  2016cites this paper
• Prostatakrebs – eine Zivilisationskrankheit?

  2016cites this paper
• The Risk Factors of Prostate Cancer and Its Prevention: A Literature Review.

  2016cites this paper
• Body size across the life course and prostate cancer in the Health Professionals Follow‐up Study

  2016cites this paper
• Prostate Cancer Prevention: Strategies and Realities

  2016cites this paper
• Nutrient restriction in combinatory therapy of tumors

  2016cites this paper
• Obesity and Prostate Cancer.

  2016cites this paper
• Nutrient restriction in combinatory therapy of tumors

  2016cites this paper
• Current perspectives between metabolic syndrome and cancer

  2016cites this paper
• miR-483 is Down-Regulated in Polycystic Ovarian Syndrome and Inhibits KGN Cell Proliferation via Targeting Insulin-Like Growth Factor 1 (IGF1)

  2016cites this paper
• Long-term safety of growth hormone replacement therapy after childhood medulloblastoma and PNET: it is time to set aside old concerns

  2016cites this paper
• Sekundäre Prävention bei Patienten mit oberflächlichem Urothelkarzinom

  2015cites this paper
• Prediagnostic plasma IGFBP‐1, IGF‐1 and risk of prostate cancer

  2015cites this paper
• Body fatness as a cause of cancer: epidemiologic clues to biologic mechanisms.

  2015cites this paper
• Hormonal and genetic regulation of prostate cancer in Caucasian and Malaysian Chinese ethnic groups

  2015cites this paper
• [Secondary prevention in patients with superficial urothelial carcinoma].

  2015cites this paper
• A prospective study of plasma 25-hydroxyvitamin D concentration and prostate cancer risk

  2015cites this paper
• Increased expression of insulin-like growth factor-1 receptor is correlated with worse survival in canine appendicular osteosarcoma.

  2015cites this paper
• Significance of S 100 A 4 expression in prostatic adenocarcinoma

  2015cites this paper
• WHO classification of tumours of female reproductive organs

  2014cites this paper
• The Diabetes-Cancer Link

  2014cites this paper
• The Role of Human Insulin Growth Factor (Igf) – Axis in Carcinogenesis

  2014cites this paper
• Dairy products and risk of hepatocellular carcinoma: The European Prospective Investigation into Cancer and Nutrition

  2014cites this paper
• Nutrition, hormones and prostate cancer risk: results from the European prospective investigation into cancer and nutrition.

  2014cites this paper
• Association of IGF1R polymorphisms with the development of HBV-related hepatocellular carcinoma.

  2014cites this paper
• Dietary total and insoluble fiber intakes are inversely associated with prostate cancer risk.

  2014cites this paper
• Caloric restriction and cancer: molecular mechanisms and clinical implications.

  2014cites this paper
• Fine-Mapping IGF1 and Prostate Cancer Risk in African Americans: The Multiethnic Cohort Study

  2014cites this paper
• Genetic and Dietary Determinants of Insulin-Like Growth Factor (IGF)-1 and IGF Binding Protein (BP)-3 Levels among Chinese Women

  2014cites this paper
• Childhood height and body mass index were associated with risk of adult thyroid cancer in a large cohort study.

  2014cites this paper
• The Effects of Suplatast Tosilate Treatment and Prophylaxis on Lung Histopathology in a Mouse Model of Chronic Asthma

  2014cites this paper
• Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis

  2014cites this paper
• Coffee consumption and risk of nonaggressive, aggressive and fatal prostate cancer--a dose-response meta-analysis.

  2014cites this paper
• Growth factor and signaling pathways and their relevance to prostate cancer therapeutics

  2014cites this paper
• Association of Body Weight With the Risk for Malignancies in Hospitalized Patients With or Without Diabetes Mellitus in Taiwan

  2014cites this paper
• Coffee consumption and risk of nonaggressive, aggressive and fatal prostate cancer—a dose-response

  2013cites this paper
• Insulin resistance and cancer: the role of insulin and IGFs.

  2013influential citation
• Childhood Height and Birth Weight in Relation to Future Prostate Cancer Risk: A Cohort Study Based on the Copenhagen School Health Records Register

  2013cites this paper
• Height as an explanatory factor for sex differences in human cancer.

  2013cites this paper
• Insulin-Like Growth Factors and Insulin-Like Growth Factor–Binding Proteins and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial

  2013cites this paper
• Calorie restriction and cancer prevention: a mechanistic perspective

  2013cites this paper
• Epidemiological studies of diet quality, body size and prostate cancer risk

  2013cites this paper
• Uptodate on GH/IGF-1 axis actions

  2013cites this paper
• Guidelines on Prostate Cancer

  2013cites this paper
• Calorie Restriction and Cancer Prevention: Established and Emerging Mechanisms

  2013cites this paper
• Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer

  2013cites this paper